BRCA and Early Events in the Development of Serous Ovarian Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2014.00005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

BRCA Mutations in the Manifestation and Treatment of Ovarian Cancer

Oncotarget
Oncology
2017English

Notch Signaling in Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2014English

Notch Signaling in Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2014English

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

Genomic Copy Number Alterations in Serous Ovarian Cancer

2018English

UK BRCA Mutation Testing in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Proteome Profiling of Low Grade Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Chemoresistance‑associated Alternative Splicing Signatures in Serous Ovarian Cancer

Oncology Letters
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy